This content is machine translated Myeloid diseases New trends in the treatment of acute myeloid leukemia Understanding about myeloid diseases, such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), is becoming more concrete thanks to intensive research. Recent study results have shown that there is…
View Post 10 min This content is machine translated Myelodysplastic syndromes WHO classification and use of “next-generation” sequencing With the aging of society, MDS diseases are also on the rise. However, developments in molecular diagnostics and new therapies will also change management for older patients. A multidisciplinary approach…
View Post 5 min This content is machine translated EHA Congress in Vienna Myelodysplastic syndromes – data from clinical practice. At the 20th EHA Congress in Vienna, experts discussed the therapeutic situation in myelodysplastic syndromes. How does the frequently prescribed active ingredient azacitidine perform in practice? Data from a Dutch…
View Post 7 min This content is machine translated The Anemic Elderly Patient in Family Practice What should be considered? The incidence of anemia increases with age and cannot be considered a normal physiological sign of aging. In persons over 65 years of age, the prevalence of anemia ranges from…
View Post 4 min This content is machine translated Multiple Myeloma and MDS Something has happened in therapy The diagnosis and treatment of multiple myeloma (MM) and myelodysplastic syndromes (MDS) have undergone great development in recent years. Modern diagnostic procedures became qualitatively better and more widely available, new…
View Post 4 min This content is machine translated Hematology New possibilities thanks to targeted therapy At the DGHO congress in Vienna, the focus was on new targeted therapies designed to improve the quality of life of patients with malignant hematologic diseases. In particular, medical advances…
